Rajnikant B. Patel

Array ( [id] => 10735930 [patent_doc_number] => 20160082079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'Wnt Antagonist and Methods of Treatment and Screening' [patent_app_type] => utility [patent_app_number] => 14/842398 [patent_app_country] => US [patent_app_date] => 2015-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 39264 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14842398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12001887 [patent_doc_number] => 20170306042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'IMMUNOGENIC MODULATION BY ENDOCRINE DEPRIVATION THERAPY IMPROVES SENSITIVITY OF TUMOR CELLS TO IMMUNE MEDIATED LYSIS' [patent_app_type] => utility [patent_app_number] => 15/507316 [patent_app_country] => US [patent_app_date] => 2015-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11462 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11018085 [patent_doc_number] => 20160215039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'AGENTS AND METHODS BASED ON THE USE OF THE EDA DOMAIN OF FIBRONECTIN' [patent_app_type] => utility [patent_app_number] => 14/835764 [patent_app_country] => US [patent_app_date] => 2015-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13605 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14835764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13345833 [patent_doc_number] => 20180224456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => METHOD FOR DETERMINING A SUBJECT'S PROBABILITY TO SUFFER FROM PANCREATIC CANCER [patent_app_type] => utility [patent_app_number] => 15/506425 [patent_app_country] => US [patent_app_date] => 2015-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13802 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12023673 [patent_doc_number] => 20170313771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'Antibody for Recognizing Specific Motif of WLS Protein, and Pharmaceutical Composition Comprising Same' [patent_app_type] => utility [patent_app_number] => 15/518077 [patent_app_country] => US [patent_app_date] => 2015-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 12780 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15518077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11944426 [patent_doc_number] => 20170248578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'ANTI-CANCER AGENT SENSITIVITY-DETERMINING MARKER' [patent_app_type] => utility [patent_app_number] => 15/503878 [patent_app_country] => US [patent_app_date] => 2015-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10964 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11031617 [patent_doc_number] => 20160228573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'LIPOSOME ENCAPSULATED AFFINITY DRUG' [patent_app_type] => utility [patent_app_number] => 14/826967 [patent_app_country] => US [patent_app_date] => 2015-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 19336 [patent_no_of_claims] => 142 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14826967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11867595 [patent_doc_number] => 20170234880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'DIAGNOSIS OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/503155 [patent_app_country] => US [patent_app_date] => 2015-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18206 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17329231 [patent_doc_number] => 11219672 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-11 [patent_title] => Therapeutic agent for cancer which comprises combination of IL-18 and molecule-targeting antibody [patent_app_type] => utility [patent_app_number] => 15/501760 [patent_app_country] => US [patent_app_date] => 2015-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 23029 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10445982 [patent_doc_number] => 20150330996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'DETECTION OF HISTONE MODIFICATION IN CELL-FREE NUCLEOSOMES' [patent_app_type] => utility [patent_app_number] => 14/816329 [patent_app_country] => US [patent_app_date] => 2015-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8582 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14816329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10453398 [patent_doc_number] => 20150338412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'COMPOSITION FOR DIAGNOSIS OF LUNG CANCER AND DIAGNOSIS KIT FOR LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 14/816335 [patent_app_country] => US [patent_app_date] => 2015-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6311 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14816335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11077154 [patent_doc_number] => 20160274118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'BIOMARKER OF LIVER CANCER AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/812269 [patent_app_country] => US [patent_app_date] => 2015-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10141 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11837872 [patent_doc_number] => 20170219592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => 'PREDICTION OF CANCER TREATMENT BASED ON DETERMINATION OF ENZYMES OR METABOLITES OF THE KYNURENINE PATHWAY' [patent_app_type] => utility [patent_app_number] => 15/328669 [patent_app_country] => US [patent_app_date] => 2015-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12156 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10679589 [patent_doc_number] => 20160025734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'USE OF URINARY PROTEIN BIOMARKERS TO DISTINGUISH BETWEEN NEOPLASTIC AND NON-NEOPLASTIC DISEASE OF THE PROSTATE' [patent_app_type] => utility [patent_app_number] => 14/805668 [patent_app_country] => US [patent_app_date] => 2015-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17062 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14805668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11670381 [patent_doc_number] => 20170159101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'DRUG-RESISTANT P97 ATPASE MUTATIONS' [patent_app_type] => utility [patent_app_number] => 15/324718 [patent_app_country] => US [patent_app_date] => 2015-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17194 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11619771 [patent_doc_number] => 20170129958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 15/318370 [patent_app_country] => US [patent_app_date] => 2015-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12661 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15318370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11618172 [patent_doc_number] => 20170128360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 15/319386 [patent_app_country] => US [patent_app_date] => 2015-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5624 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13890051 [patent_doc_number] => 10197572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-05 [patent_title] => Method and kit for detection of deltanoid-resistant leukemia cells and antibody for use therein [patent_app_type] => utility [patent_app_number] => 15/320738 [patent_app_country] => US [patent_app_date] => 2015-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5245 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11589722 [patent_doc_number] => 20170114133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'TEM8 ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/317048 [patent_app_country] => US [patent_app_date] => 2015-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18208 [patent_no_of_claims] => 119 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10722459 [patent_doc_number] => 20160068606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS' [patent_app_type] => utility [patent_app_number] => 14/732537 [patent_app_country] => US [patent_app_date] => 2015-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 77 [patent_no_of_words] => 88269 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732537 [rel_patent_id] =>[rel_patent_doc_number] =>)